Senior insider sale
CEO and President at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$643.3K
152.70K shares
What this filing means
KHAN NAJAT plans to sell 152.70K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $643.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/9/2026ACC: 0001628280-26-015905
DirectorOfficer· CEO and President
Since Feb 2026
152.70K
Shares to sell
$643.3K
Approx. market value
28.30K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Equity Compensation
Equity Compensation
2/15/2026
28.30KTotal acquired28.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/15/2026 | Equity Compensation Equity Compensation | 28.30K | — |
| Total | 28.30K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
124.40K
Market value
$548.6K
12/22/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
28.30K
Market value
$94.7K
3/9/2026
Total
Units
152.70K
Value
$643.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/22/2025 | 124.40K | $548.6K | — | Completed |
| Planned — Approximate Date | ||||
3/9/2026 | 28.30K | $94.7K | NASDAQ | Planned |
| Total | 152.70K | $643.3K | ||